pyridoxine has been researched along with Local Neoplasm Recurrence in 9 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, F | 1 |
Chen, K | 1 |
Soloway, MS | 1 |
Pavone-Macaluso, M | 1 |
Tripi, M | 1 |
Ingargiola, GB | 1 |
Newling, DW | 1 |
Robinson, MR | 1 |
Smith, PH | 1 |
Byar, D | 2 |
Lockwood, R | 1 |
Stevens, I | 1 |
De Pauw, M | 1 |
Sylvester, R | 1 |
Lamm, DL | 1 |
Allaway, M | 1 |
Lindsey, JK | 1 |
Blackard, C | 1 |
Katayama, Y | 1 |
Niijima, T | 1 |
1 review available for pyridoxine and Local Neoplasm Recurrence
Article | Year |
---|---|
Current trends in bladder cancer treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Cohort Studies; Cystectomy; | 2000 |
4 trials available for pyridoxine and Local Neoplasm Recurrence
Article | Year |
---|---|
Systemic therapy for superficial bladder cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Clinical Trials as Topic; Cyclophospha | 1984 |
Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
Topics: Antineoplastic Agents; Carcinoma, Papillary; Cisplatin; Clinical Trials as Topic; Combined Modality | 1983 |
Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative G
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional | 1995 |
Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.
Topics: Administration, Oral; Administration, Topical; Clinical Trials as Topic; Drug Evaluation; Follow-Up | 1977 |
4 other studies available for pyridoxine and Local Neoplasm Recurrence
Article | Year |
---|---|
Case-cohort analysis of clusters of recurrent events.
Topics: Cluster Analysis; Cohort Studies; Computer Simulation; Humans; Likelihood Functions; Neoplasm Recurr | 2014 |
A general family of distributions for longitudinal dependence with special reference to event histories.
Topics: Antineoplastic Agents, Alkylating; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Longitu | 2001 |
[A study of prophylaxis for recurrence of bladder tumor. Some statistical and experimental studies on the long term administration of -glucuronidase inhibitor (2,5-di-o-acetyl, D-glucaro(1-4)(6-3) dilactone) to patients of bladder tumor].
Topics: Adipates; Administration, Oral; Adult; Aged; Female; Glucuronates; Glucuronidase; Humans; Lactones; | 1972 |
[Problems of recurrence of bladder tumor].
Topics: Antineoplastic Agents; Glucuronidase; Humans; Neoplasm Recurrence, Local; Pyridoxine; Tryptophan; Ur | 1971 |